The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities.
Journal
PharmacoEconomics - open
ISSN: 2509-4254
Titre abrégé: Pharmacoecon Open
Pays: Switzerland
ID NLM: 101700780
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
5
9
2018
medline:
5
9
2018
entrez:
5
9
2018
Statut:
ppublish
Résumé
Web surveys are often used for utility valuation. Typically, custom utility valuation tools that have not undergone psychometric evaluation are used. This study aimed to determine the psychometric properties of a metastatic epidural spinal cord compression (MESCC) module run on a customizable open-source, internet-based, self-directed utility valuation platform (Self-directed Online Assessment of Preferences [SOAP]). Individuals accompanying patients to the emergency department waiting room in Ottawa, Canada, were recruited. Participants made SOAP MESCC health state valuations in the waiting room and 48 h later at home. Validity, agreement reliability, and responsiveness were measured by logical consistency of responses, smallest detectable change, the interclass correlation coefficient, and Guyatt's responsiveness index, respectively. Of 285 participants who completed utility valuations, only 113 (39.6%) completed the re-test. Of these 113 participants, 92 (81.4%) provided valid responses on the first test and 75 (66.4%) provided valid responses on the test and re-test. Agreement for all groups of health states was adequate, since their smallest detectable change was less than the minimal clinically important difference. The mean interclass correlation coefficients for all health states were > 0.8, indicating at least substantial reliability. Guyatt's responsiveness indices all exceeded 0.80, indicating a high level of responsiveness. To our knowledge, this is the first validated open-source, web-based, self-directed utility valuation module. We have demonstrated the SOAP MESCC module is valid, reproducible, and responsive for obtaining ex ante utilities. Considering the successful psychometric validation of the SOAP MESCC module, other investigators can consider developing modules for other diseases where direct utility valuation is needed.
Identifiants
pubmed: 30178420
doi: 10.1007/s41669-018-0092-1
pii: 10.1007/s41669-018-0092-1
pmc: PMC6533369
doi:
Types de publication
Journal Article
Langues
eng
Pagination
197-204Références
J Health Econ. 1996 Apr;15(2):209-31
pubmed: 10159110
J Clin Epidemiol. 1999 Nov;52(11):1047-53
pubmed: 10526998
J Clin Epidemiol. 2000 May;53(5):459-68
pubmed: 10812317
Int J Technol Assess Health Care. 2001 Fall;17(4):479-87
pubmed: 11758292
Med Decis Making. 2002 Nov-Dec;22(6):464-74
pubmed: 12458976
Health Econ. 2003 Jul;12(7):529-44
pubmed: 12825206
Med Decis Making. 2004 Jan-Feb;24(1):53-60
pubmed: 15005954
Med Care. 2005 Mar;43(3):221-8
pubmed: 15725978
J Clin Oncol. 2005 May 20;23(15):3358-65
pubmed: 15738534
Med Decis Making. 2005 Jul-Aug;25(4):460-7
pubmed: 16061898
Lancet. 2005 Aug 20-26;366(9486):643-8
pubmed: 16112300
Med Decis Making. 2006 Mar-Apr;26(2):173-81
pubmed: 16525171
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Health Qual Life Outcomes. 2007 Dec 21;5:70
pubmed: 18154669
Value Health. 2008 Mar;11 Suppl 1:S3-10
pubmed: 18387064
Value Health. 2009 Mar;12 Suppl 1:S27-30
pubmed: 19250128
Value Health. 2009 Mar;12 Suppl 1:S5-9
pubmed: 19250132
Radiother Oncol. 2009 Nov;93(2):174-9
pubmed: 19520448
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Int J Technol Assess Health Care. 2011 Jan;27(1):71-6
pubmed: 21262069
PLoS One. 2012;7(2):e31115
pubmed: 22328929
Pharmacoeconomics. 2013 Apr;31(4):305-15
pubmed: 23512145
Health Qual Life Outcomes. 2013 Jun 03;11:90
pubmed: 23731777
Eur J Health Econ. 2013 Jul;14 Suppl 1:S25-31
pubmed: 23900662
Qual Life Res. 2014 Mar;23(2):377-84
pubmed: 23943291
J Med Econ. 2013 Nov;16(11):1357-65
pubmed: 24111563
Plast Reconstr Surg. 2014 Apr;133(4):827-40
pubmed: 24352209
Can J Diabetes. 2014 Feb;38(1):45-52
pubmed: 24485213
J Pediatr Urol. 2014 Dec;10(6):1026-31
pubmed: 24766856
Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2):155-63
pubmed: 25648463
Health Qual Life Outcomes. 2015 Jul 02;13:94
pubmed: 26135391
Med Decis Making. 2016 Oct;36(7):798-810
pubmed: 26209475
J Clin Epidemiol. 1989;42(5):403-8
pubmed: 2659745
J Clin Oncol. 2016 Jan 20;34(3):268-76
pubmed: 26598751
Value Health. 2015 Dec;18(8):1025-36
pubmed: 26686787
Qual Life Res. 2016 Sep;25(9):2179-91
pubmed: 27016943
Value Health. 2016 Mar-Apr;19(2):226-32
pubmed: 27021757
J Med Econ. 2016 Oct;19(10):945-58
pubmed: 27149402
BMC Psychiatry. 2016 Jul 16;16:244
pubmed: 27421880
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
J Chronic Dis. 1987;40(2):171-8
pubmed: 3818871
Med Care. 1984 Jun;22(6):543-52
pubmed: 6738144
Med Decis Making. 1994 Jan-Mar;14(1):82-90
pubmed: 8152360
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
JAMA. 1996 Oct 16;276(15):1253-8
pubmed: 8849754